NCT04202653View on ClinicalTrials.gov

Combination of ETV, TQ-A3334 and TQ-B2450 for CHB (Neptune Study)

PHASE2UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

December 31, 2020

Study Completion Date

June 30, 2021

Conditions
Chronic Hepatitis b
Interventions
DRUG

ETV

entecavir 0.5 mg qd

DRUG

TQ-A3334

TQ-A3334 po qw

DRUG

TQ-B2450

TQ-B2450 q3w iv

Sponsors
All Listed Sponsors
collaborator

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY

lead

Tongji Hospital

OTHER